Mersana Therapeutics, Inc.
MRSN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69 | -$172 | -$204 | -$170 |
| Dep. & Amort. | $2 | $2 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $16 | $21 | $22 | $18 |
| Change in WC | -$31 | -$19 | $133 | $10 |
| Other Non-Cash | -$0 | -$1 | -$1 | $1 |
| Operating Cash Flow | -$82 | -$169 | -$49 | -$140 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$2 | -$1 |
| Net Acquisitions | $0 | $0 | $151 | $0 |
| Inv. Purchases | -$133 | -$156 | -$248 | $0 |
| Inv. Sales/Matur. | $145 | $278 | $97 | $0 |
| Other Inv. Act. | $0 | $0 | -$151 | $0 |
| Investing Cash Flow | $11 | $120 | -$153 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2 | -$0 | -$0 | $18 |
| Stock Issued | $6 | $94 | $151 | $43 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $1 | $2 | $2 |
| Financing Cash Flow | $4 | $95 | $153 | $64 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$67 | $46 | -$49 | -$77 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $175 | $129 | $178 | $255 |
| End Cash | $108 | $175 | $129 | $178 |
| Free Cash Flow | -$82 | -$171 | -$52 | -$141 |